News & Articles
MediXSpace partners up with Oncoatlas
Our joint effort in enhancing the effectiveness of the Virtual Tumor Board is getting acknowledged by experts
We are delighted to confirm that our first Molecular Tumor Boards have been acknowledged by the geneticists from the Oncoatlas team. Our solution has proven to facilitate access to multidisciplinary expertise, which is often crucial for defining the right treatment strategy.
The practical result of our work is yet to be evaluated in a few months. The expert teams will access the condition of the first patients whose cases have been reviewed by the Molecular Tumor Board. Some of our findings will be presented at the HiMSS Conference in Orlando, USA in March 2022.